Metallothionein 2A expression is associated with cell proliferation in breast cancer

被引:187
作者
Jin, RX
Chow, VTK
Tan, PH
Dheen, ST
Duan, W
Bay, BH
机构
[1] Natl Univ Singapore, Dept Anat, Singapore S117597, Singapore
[2] Natl Univ Singapore, Dept Microbiol, Singapore S117597, Singapore
[3] Natl Univ Singapore, Dept Biochem, Singapore S117597, Singapore
[4] Singapore Gen Hosp, Dept Pathol, Singapore S169608, Singapore
关键词
D O I
10.1093/carcin/23.1.81
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Metallothioneins (MTs) belong to a family of cysteine-rich, metal-binding intracellular proteins, which have been linked with cell proliferation. In this study, expression levels of the 8 known MT-1 and MT-2 functional isoforms in human invasive ductal breast cancer specimens were determined by RT-PCR. The expression profiles of the MT protein and MT-2A mRNA were further evaluated in 79 cases of human invasive ductal breast carcinoma by immunohistochemistry and in situ hybridization, and correlated with cancer cell proliferation (determined by Ki-67 nuclear antigen immunolabeling). MT-1A, MT-1E, MT-1F, MT-1G, MT-1H, MT-1X and MT-2A but not MT-1B, were detected in breast cancer tissue samples. The MT-2A mRNA transcript was the highest among all the isoforms detected. A positive correlation was observed between MT-2A mRNA and MT protein expression with Ki-67 labeling (P = 0.0003 and P < 0.0001, respectively) but not with apoptosis (P = 0.1244 and P = 0.8189, respectively). Co-localization of the MT protein and Ki-67 nuclear antigen in breast cancer cells was demonstrated by double immunofluorescence staining. There was also significantly higher MT protein and MT-2A mRNA expression in histological grade 3 tumors than in histological grade 1 and 2 tumors. The finding that MT 2A appears to be the main isoform associated with cell proliferation in invasive ductal breast cancer tissues, may have therapeutic implications.
引用
收藏
页码:81 / 86
页数:6
相关论文
共 53 条
[1]  
Abdel-Mageed AB, 1998, CANCER RES, V58, P2335
[2]  
AbdelMageed AB, 1997, CANCER GENE THER, V4, P199
[3]   Bcl-2 protein expression in breast cancer in relation to established prognostic factors and other clinicopathological variables [J].
Binder, C ;
Marx, D ;
Overhoff, R ;
Binder, L ;
Schauer, A ;
Hiddemann, W .
ANNALS OF ONCOLOGY, 1995, 6 (10) :1005-1010
[4]  
Cai L, 1998, ANTICANCER RES, V18, P4667
[5]   Reversible zinc exchange between metallothionein and the estrogen receptor zinc finger [J].
CanoGauci, DF ;
Sarkar, B .
FEBS LETTERS, 1996, 386 (01) :1-4
[6]   CELL-SPECIFIC AND INDUCER-SPECIFIC ACCRETION OF HUMAN ISOMETALLOTHIONEINS [J].
CAVIGELLI, M ;
KAGI, JHR ;
HUNZIKER, PE .
BIOCHEMICAL JOURNAL, 1993, 292 :551-554
[7]  
Cherian M G, 1987, Experientia Suppl, V52, P499
[8]  
CHERIAN MG, 1993, CANCER RES, V53, P922
[9]   GAIN OF FUNCTION MUTATIONS IN P53 [J].
DITTMER, D ;
PATI, S ;
ZAMBETTI, G ;
CHU, S ;
TERESKY, AK ;
MOORE, M ;
FINLAY, C ;
LEVINE, AJ .
NATURE GENETICS, 1993, 4 (01) :42-46
[10]  
Elston C. W., 1998, BREAST, P365